BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3476196)

  • 1. Altered regulation of c-myc in an HL-60 differentiation resistant subclone, HL-60-1E3.
    Ely CM; Leftwich JA; Chenevix-Trench G; Hall RE; Westin EH
    Cancer Res; 1987 Sep; 47(17):4595-600. PubMed ID: 3476196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin structure of the c-myc gene in HL-60 cells during alterations of transcriptional activity.
    Grosso LE; Pitot HC
    Cancer Res; 1985 Oct; 45(10):5035-41. PubMed ID: 3861242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytic differentiation of HL-60 promyelocytic leukemia cells correlates with the induction of Bcl-xL.
    Chatterjee D; Han Z; Mendoza J; Goodglick L; Hendrickson EA; Pantazis P; Wyche JH
    Cell Growth Differ; 1997 Oct; 8(10):1083-9. PubMed ID: 9342186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine.
    Yen A; Forbes ME
    Cancer Res; 1990 Mar; 50(5):1411-20. PubMed ID: 2302706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.
    Zwelling LA; Hinds M; Chan D; Altschuler E; Mayes J; Zipf TF
    Cancer Res; 1990 Nov; 50(22):7116-22. PubMed ID: 2171756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased c-myc RNA levels associated with the precommitment state during HL-60 myeloid differentiation.
    Yen A; Guernsey DL
    Cancer Res; 1986 Aug; 46(8):4156-61. PubMed ID: 3460694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HL-60-1E3, a novel phorbol diester-resistant HL-60 cell line.
    Leftwich JA; Carlson P; Adelman B; Hall RE
    Cancer Res; 1987 Mar; 47(5):1319-24. PubMed ID: 3028607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.
    Gailani D; Cadwell FJ; O'Donnell PS; Hromas RA; Macfarlane DE
    Cancer Res; 1989 Oct; 49(19):5329-33. PubMed ID: 2670202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of phorbol diester-induced HL-60-mediated cytotoxicity by retinoic acid, dimethyl sulfoxide, and 5-azacytidine.
    Leftwich JA; Hall RE
    Cancer Res; 1986 Aug; 46(8):3789-92. PubMed ID: 2425933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
    Boise LH; Gorse KM; Westin EH
    Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations of mechanisms of drug-induced changes in gene expression: N-methylformamide-induced changes in synthesis of the M(r) 72,000 constitutive heat shock protein during commitment of HL-60 cells to granulocyte differentiation.
    Beere HM; Morimoto RI; Hickman JA
    Cancer Res; 1993 Jul; 53(13):3034-9. PubMed ID: 8319210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of c-myc expression to differentiation and proliferation of HL-60 cells.
    Filmus J; Buick RN
    Cancer Res; 1985 Feb; 45(2):822-5. PubMed ID: 3855381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).
    Kraft AS; Baker VV; May WS
    Oncogene; 1987 May; 1(2):111-8. PubMed ID: 3325877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of c-myc during chemically induced differentiation of HL-60 cultures.
    Grosso LE; Pitot HC
    Cancer Res; 1985 Feb; 45(2):847-50. PubMed ID: 2578312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-specific binding of a c-myc nuclear-matrix-associated region shows increased nuclear matrix retention after leukemic cell (HL-60) differentiation.
    Chou RH; Churchill JR; Mapstone DE; Flubacher MM
    Am J Anat; 1991 Jul; 191(3):312-20. PubMed ID: 1927975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
    Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
    Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding of [3H]phorbol dibutyrate to phorbol diester-responsive and -resistant clones of a human myeloid leukemia (KG-1) line 1.
    Lehrer RI; Cohen LE; Koeffler HP
    Cancer Res; 1983 Aug; 43(8):3563-6. PubMed ID: 6574815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
    Kharbanda SM; Sherman ML; Spriggs DR; Kufe DW
    Cancer Res; 1988 Nov; 48(21):5965-8. PubMed ID: 2901907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense c-myc fragments induce normal differentiation cycles in HL-60 cells.
    Chen JP; Chen L; Leek J; Lin C
    Eur J Clin Invest; 2006 Jan; 36(1):49-57. PubMed ID: 16403010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.